Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
Clinical trial NCT03601637 · COMPLETED
Trial details
- NCT number
- NCT03601637
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2021-10-29
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.